Visit us at Medica, Dusseldorf, Germany 17-20 November 2025 at Hall 16, Stand D17-5 and ask us about our free AI tools and the document builder.
Pure Global

CREATINE KINASE (CK) - ANVISA Registration 80048490061

Access comprehensive regulatory information for CREATINE KINASE (CK) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80048490061 and manufactured by MONOBIND INC. The registration is held by USA DIAGNOSTICA LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including GOLD ANALISA DIAGNOSTICA LTDA, KATAL BIOTECNOLOGICA INDÚSTRIA E COMÉRCIO LTDA, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Competitors
5 Recent Registrations
80048490061
Registration Details
ANVISA Registration Number: 80048490061
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Free consultation

Device Details

CK-MB (CREATINE KINASE) TEST SYSTEM
Risk Class II

Registration Details

80048490061

25351316198201037

02330159000108

Company Information

MONOBIND INC
United States of America
PT: ESTADOS UNIDOS DA AMÉRICA

Dates and Status

Feb 06, 2012

VIGENTE

09/18/2025 19:00:01